Asteria Health Recalls Testosterone and Anastrozole Sterile Pellets Due to Potential Metal Contamination
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
F.H. INVESTMENTS, Inc. (dba Asteria Health) has issued a voluntary recall for Testosterone and Anastrozole sterile pellets due to the potential presence of metal particulate matter.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Drugs.
What Happened
F.H. INVESTMENTS, Inc., doing business as Asteria Health, has initiated a voluntary recall of specific sterile pellets containing Testosterone and Anastrozole. The recall was triggered by the discovery of a foreign substance, specifically the potential presence of metal particulate matter, within the product. This recall has been classified as Class II by the FDA.
Which Products Are Affected
The recall involves 100 units of the following product:
- Product Name: Testosterone 100mg, Anastrozole 4mg (4.5), 1 Sterile Pellet
- Brand: Asteria Health
- NDC: 79559-4104-01
- Lot Number: 254000104
- Expiration Date: 05/27/2026
These products were distributed nationwide across the United States.
What You Should Do
Consumers and healthcare professionals should immediately stop using the affected lot. The firm initiated the recall via letter on January 26, 2026. For further information regarding returns or specific medical concerns, consumers may contact F.H. INVESTMENTS, Inc. (dba Asteria Health) at their Birmingham, Alabama facility located at 432 Industrial Ln, Birmingham, AL 35211-4465.
Why This Matters
The presence of foreign metal particulates in a sterile pellet intended for medical use poses a serious health risk, as it can lead to local inflammation, irritation, or other complications at the site of administration.
Source
Information provided by the FDA under Recall Number D-0326-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.